The overall goal of the proposed research is to determine how the transcriptional enhancer of the Moloney murine leukemia virus regulates the expression of the virus in lymphoid and myeloid hematopoietic cells, and contributes to the T cell specificity of transformation. In vitro characterization of the Moloney enhancer has identified a complex array of nuclear factor binding sites. Our recent genetic analysis has enabled us to identify two of these sites, the LVb site and adjacent core element as important determinants of the thymic disease specificity of the Moloney virus. We now plan to use molecular genetics and biochemistry to further characterize the nuclear proteins that associate with the LVb/core region of the Moloney enhancer. We also plan to identify Moloney enhancer sequences that regulate viral gene expression in myeloid cells.
Our specific aims are: 1. To identify and characterize nuclear proteins that bind to the LVb/core element in the Moloney enhancer. Microaffinity DNA precipitation assays will be used to identify and distinguish between ubiquitous, tissue specific, and TPA inducible nuclear factors that bind to the LVb/core region of the Moloney enhancer. 2. To obtain and characterize T cell specific cDNA clones that encode the core-binding protein. cDNA libraries prepared from T cells will be screened for core binding factors by one of the methods listed in 2.1 - 2.3 isolated cDNA clones will be characterized for DNA binding specificity, sequenced, and analyzed for tissue-specific expression. 3. To identify enhancer sequences that mediate transcription from the Moloney enhancer in myeloid cells. A panel of Moloney enhancer mutants, each containing a point mutation in one of the nuclear factor binding sites on the enhancer, will be analyzed for transcriptional activity in myeloid leukemia cell lines representing progressive stages of differentiation, by transient CAT assays.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA051065-04
Application #
3459704
Study Section
Experimental Virology Study Section (EVR)
Project Start
1990-09-30
Project End
1995-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Zaiman, A L; Lewis, A F; Crute, B E et al. (1995) Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores. J Virol 69:2898-906
Wotton, D; Ghysdael, J; Wang, S et al. (1994) Cooperative binding of Ets-1 and core binding factor to DNA. Mol Cell Biol 14:840-50
Sun, W; O'Connell, M; Speck, N A (1993) Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers. J Virol 67:1976-86
Manley, N R; O'Connell, M; Sun, W et al. (1993) Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers. J Virol 67:1967-75
Melnikova, I N; Crute, B E; Wang, S et al. (1993) Sequence specificity of the core-binding factor. J Virol 67:2408-11
Wang, S; Wang, Q; Crute, B E et al. (1993) Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13:3324-39
Prosser, H M; Wotton, D; Gegonne, A et al. (1992) A phorbol ester response element within the human T-cell receptor beta-chain enhancer. Proc Natl Acad Sci U S A 89:9934-8
Wang, S W; Speck, N A (1992) Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol Cell Biol 12:89-102